Brokers Issue Forecasts for Daré Bioscience, Inc.'s Q3 2023 Earnings (NASDAQ:DARE) : vimarsana.com

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – Brookline Capital Management issued their Q3 2023 earnings estimates for Daré Bioscience in a report released on Monday, June 5th. Brookline Capital Management analyst K. Dolliver expects that the biotechnology company will earn ($0.07) per share for the quarter. Brookline Capital Management currently has a “Buy” rating […]

Related Keywords

Lisa Walters Hoffert , Sabrina Martucci Johnson , Blackrock Inc , Vanguard Group Inc , Renaissance Technologies , Millennium Management , Bioscience Inc , Nasdaq , Get Rating , Brookline Capital Management , Capital Management , Bioscience Price , Funds Weigh In On Dar , State Street Corp , Street Corp , Bioscience Daily , Daré Bioscience , Nasdaq Dare , Dare , Medical , Earnings Estimates ,